Jiangsu Gdk Biological Technology Past Earnings Performance
Past criteria checks 0/6
Jiangsu Gdk Biological Technology's earnings have been declining at an average annual rate of -44.5%, while the Biotechs industry saw earnings growing at 5.4% annually. Revenues have been declining at an average rate of 42% per year.
Key information
-44.5%
Earnings growth rate
-45.5%
EPS growth rate
| Biotechs Industry Growth | 11.3% |
| Revenue growth rate | -42.0% |
| Return on equity | -9.5% |
| Net Margin | -385.8% |
| Next Earnings Update | 21 Aug 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Jiangsu Gdk Biological Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 33 | -129 | 97 | 16 |
| 31 Dec 23 | 135 | -71 | 123 | 15 |
| 30 Sep 23 | 219 | -25 | 145 | 20 |
| 30 Jun 23 | 429 | 94 | 214 | 20 |
| 31 Mar 23 | 412 | 81 | 210 | 33 |
| 31 Dec 22 | 318 | 42 | 168 | 32 |
| 30 Sep 22 | 264 | 38 | 132 | 31 |
| 30 Jun 22 | 377 | 89 | 165 | 33 |
| 31 Mar 22 | 375 | 85 | 159 | 32 |
| 31 Dec 21 | 392 | 82 | 164 | 35 |
| 30 Sep 21 | 676 | 207 | 284 | 35 |
| 30 Jun 21 | 534 | 138 | 223 | 35 |
| 31 Mar 21 | 578 | 146 | 260 | 26 |
| 31 Dec 20 | 589 | 155 | 271 | 29 |
| 31 Dec 19 | 67 | -19 | 58 | 24 |
Quality Earnings: 688670 is currently unprofitable.
Growing Profit Margin: 688670 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688670 is unprofitable, and losses have increased over the past 5 years at a rate of 44.5% per year.
Accelerating Growth: Unable to compare 688670's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 688670 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-7.5%).
Return on Equity
High ROE: 688670 has a negative Return on Equity (-9.55%), as it is currently unprofitable.